NCT05958199 2025-06-27A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7NextPoint Therapeutics, Inc.Phase 1 Suspended131 enrolled
NCT02982941 2022-02-08Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid TumorsMacroGenicsPhase 1 Completed25 enrolled
NCT02223052 2020-05-12Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCelgenePhase 1 Completed89 enrolled
NCT00154388 2016-11-18Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesNovartisPhase 2 Completed185 enrolled
NCT01169584 2016-01-21Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric PatientsSillaJen, Inc.Phase 1 Completed6 enrolled
NCT00413075 2015-07-08Study of Oral PXD101 in Patients With Advanced Solid Tumors or LymphomaValerio TherapeuticsPhase 1 Completed121 enrolled
NCT00413322 2015-07-08Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsValerio TherapeuticsPhase 1 Completed35 enrolled
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts
NCT01242072 2012-07-18Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With MalignanciesAlaunos TherapeuticsPhase 1 Unknown12 enrolled